FDA 483 - Implants International Ltd. - December 18, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Implants International, Ltd., a device manufacturer in Thornaby-on-Tees, revealed ten significant quality system deficiencies. The firm failed to adequately establish procedures for corrective and preventive actions, complaint handling, design risk analysis, incoming product acceptance, environmental controls, supplier management, non-conforming product control, process control for passivation, finished device acceptance, and design verification. These issues indicate a systemic breakdown in the firm's quality management system, particularly concerning their Rotoglide implant products.
ID · 8a90e0b0-648b-4bd0-b0e3-ff1736df1716